Donepezil for dementia with Lewy bodies: meta‐analysis of multicentre, randomised, double‐blind, placebo‐controlled phase II, III, and, IV studies

Documenti analoghi

• Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12‐week multicentre, randomised, double‐blind, and placebo‐controlled phase IV study
  di: Etsuro Mori, et al.
  Pubblicazione: (2024)
• A multimodal non‐pharmacological intervention for persons with dementia in nursing homes: a multicentre randomised controlled trial
  di: Kyosuke Yorozuya, et al.
  Pubblicazione: (2024)
• Delusional jealousy and psychological factors in very late‐onset schizophrenia‐like psychosis with positive result of Lewy body disease biomarker: a case report
  di: Hisaki Omori, et al.
  Pubblicazione: (2024)
• Response to “Difficulties in diagnosing phenoconversion to dementia in psychiatric‐onset prodromal dementia with Lewy bodies”
  di: Ryota Kobayashi, et al.
  Pubblicazione: (2024)
• Psychiatric and delirium onset dementia with Lewy bodies: two case reports
  di: Takahide Fukatsu, et al.
  Pubblicazione: (2025)